Clinical Trial Update: Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SHR4640 tablets in combination with febuxostat for primary gout and hyperuricemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• FEBUXOSTAT (Febuxostat)
• SHR4640

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Primary Gout and Hyperuricemia | Phase 2 | Status: UNKNOWN